Calidi Biotherapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Calidi Biotherapeutics, Inc. has filed 392 SEC EDGAR filings since 17 May 2021

SEC filing history

Showing 251-275 of 392 matching filings.

Per page
25
Current page
11
SC 13G/A File 005-92875

FLAG 13G/A

Filing date
10 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-92875

AMENDMENT NO. 3 TO SCHEDULE 13D

Filing date
02 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92875

SC 13D filing

Filing date
26 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-92875

SC 13D filing

Filing date
26 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Sep 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Sep 2023
Reporting date
12 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-40789

25-NSE filing

Filing date
13 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92875

SCHEDULE 13G

Filing date
08 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .